AMCP's volunteers are vital players in propelling our mission forward. In this installment of the AMCP Volunteer Spotlight, we are featuring Justin Bioc, PharmD.
In June, AMCP hosted the Deep Dive into Prescription Digital Therapeutics Summit, convening expert panelists and attendees from across the industry. Read 10 key takeaway points from the Summit.
The aim of the AMCP Format is to identify comprehensive evidence and information elements that meet the evidentiary needs of HCDMs. The AMCP Format is designed to encourage sharing of objective, credible, and relevant information on medical products.
Amyotrophic lateral sclerosis (ALS) is a rare, rapidly progressive, and fatal neurodegenerative disease characterized by loss of motor neurons in the brain and spinal cord. On April 27, AMCP convened an expert panel of clinical and managed care stakeholders to increase understanding on how payers can inform strategies to improve the care and treatment of those impacted by ALS.
June 2023 Legislative & Regulatory Briefing: AMCP Advocates Visit Congress for Legislative Days 2023; AMCP Submits Comments on Manufacturer Discount Program Draft Guidance; AMCP to Showcase Prescription Digital Therapeutics (PDTs) on Capitol Hill; AMCP Comments on Proposed Rules Regarding Privacy and Health Data; AMCP, Health Care Organizations Thank the Biden Administration for Relaunching the Cancer Moonshot.
On April 18, HHS' Office of the National Coordinator for Health Information Technology released a proposed rule titled "Health Data, Technology, and Interoperability: Certification Program Updates, Algorithm Transparency, and Information Sharing." AMCP submitted comments in response to the proposed rule on June 20.